June 05, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
CLEVELAND — The field of prurigo nodularis has seen landmark updates in the past 5 years, with clinicians expecting more potential treatments in the future, according to a speaker at Cleveland Clinic’s Medical Dermatology Therapy Update IV.Prurigo nodularis (PN), a chronic, debilitating inflammatory skin disease, affects approximately 75,000 adults in the United States. As Healio
June 05, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Find the latest Dermatology and Therapeutics news articles, videos, podcasts, and meeting coverage from medical experts and key…

CLEVELAND — After more than a decade with no new medications for chronic spontaneous urticaria, clinicians are beginning to see…

CLEVELAND — For the first time in decades, targeted therapies to treat cutaneous lupus erythematosus are advancing through the…

CLEVELAND — Researchers are uncovering triggers and treatments for cutaneous vasculitis, an inflammatory condition that damages…

Nuovo farmaco, disponibile in Italia a carico del Servizio Sanitario Nazionale: interrompe il circolo vizioso prurito…

Celldex has discontinued its Phase 2 trial of barzolvolimab for prurigo nodularis after failing to meet primary and secondary…